Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage.
OBJECTIVE
Traumatic joint injury can damage cartilage and release inflammatory cytokines from adjacent joint tissue. The present study was undertaken to study the combined effects of compression injury, tumor necrosis factor alpha (TNFalpha), and interleukin-6 (IL-6) and its soluble receptor (sIL-6R) on immature bovine and adult human knee and ankle cartilage, using an in vitro model, and to test the hypothesis that endogenous IL-6 plays a role in proteoglycan loss caused by a combination of injury and TNFalpha.


METHODS
Injured or uninjured cartilage disks were incubated with or without TNFalpha and/or IL-6/sIL-6R. Additional samples were preincubated with an IL-6-blocking antibody Fab fragment and subjected to injury and TNFalpha treatment. Treatment effects were assessed by histologic analysis, measurement of glycosaminoglycan (GAG) loss, Western blot to determine proteoglycan degradation, zymography, radiolabeling to determine chondrocyte biosynthesis, and Western blot and enzyme-linked immunosorbent assay to determine chondrocyte production of IL-6.


RESULTS
In bovine cartilage samples, injury combined with TNFalpha and IL-6/sIL-6R exposure caused the most severe GAG loss. Findings in human knee and ankle cartilage were strikingly similar to those in bovine samples, although in human ankle tissue, the GAG loss was less severe than that observed in human knee tissue. Without exogenous IL-6/sIL-6R, injury plus TNFalpha exposure up-regulated chondrocyte production of IL-6, but incubation with the IL-6-blocking Fab significantly reduced proteoglycan degradation.


CONCLUSIONS
Our findings indicate that mechanical injury potentiates the catabolic effects of TNFalpha and IL-6/sIL-6R in causing proteoglycan degradation in human and bovine cartilage. The temporal and spatial evolution of degradation suggests the importance of transport of biomolecules, which may be altered by overload injury. The catabolic effects of injury plus TNFalpha appeared partly due to endogenous IL-6, since GAG loss was partially abrogated by an IL-6-blocking Fab.
Sui
Yihong
Y
Massachusetts Institute of Technology, Cambridge, MA 01239, USA.
Lee
Jennifer H
JH
DiMicco
Michael A
MA
Vanderploeg
Eric J
EJ
Blake
Simon M
SM
Hung
Han-Hwa
HH
Plaas
Anna H K
AH
James
Ian E
IE
Song
Xiao-Yu
XY
Lark
Michael W
MW
Grodzinsky
Alan J
AJ
D000328:Adult; D000818:Animals; D016512:Ankle Injuries / Q000378:metabolism / Q000473:pathology; D001696:Biomechanical Phenomena; D002358:Cartilage, Articular / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D002417:Cattle; D002478:Cells, Cultured; D019902:Chondrocytes / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D005260:Female; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism* / Q000494:pharmacology; D007596:Joints / Q000293:injuries*; D007718:Knee Injuries / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011509:Proteoglycans / Q000378:metabolism*; D019947:Receptors, Interleukin-6 / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism* / Q000494:pharmacology
D006025:Glycosaminoglycans; D015850:Interleukin-6; D011509:Proteoglycans; D019947:Receptors, Interleukin-6; D014409:Tumor Necrosis Factor-alpha